Global Pain Management Therapeutics Market, By Pain Type (Chronic and Acute), Drug Class (NSAIDS, Anesthetics, Anticonvulsant, Anti-Migraine Drugs, Antidepressant Drugs, Opioids, Non-Narcotics and Analgesics), Indication (Arthritic Pain, Neuropathic Pain, Cancer Pain, Chronic Pain, Post-Operative Pain, Migraine, Fibromyalgia, Bone Fracture, Muscle Sprain/Strain, Acute Appendicitis and Other Indications), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights : Global Pain Management Therapeutics Market
The pain management therapeutics market is expected to witness market growth at a rate of 3.8% in the forecast period of 2021 to 2028. Data Bridge Market Research report on pain management therapeutics market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The increasing number of patients suffering from chronic pain is escalating the growth of pain management therapeutics market.
Pain refers to a disturbing sensory and emotional sensation resulting from tissue damage or disease. Several disorders cause discomfort such as multiple sclerosis, stomach ulcer, chronic arthritis, osteoarthritis, diabetic neuropathy, fibromyalgia and cancer. The length of pain may range from acute pain for short term to chronic pain for long term. Acute pain can be mild and lasts for only a moment or for weeks or months. Chronic pain is caused by aged bone and joint conditions, nerve damage or even injury. The variety of drugs are utilized for managing pain that results from inflammation in response to tissue damage, chemical agents/pathogens (nociceptive pain) or nerve damage (neuropathic pain).
The rise in the rate of geriatric population is one of the major factors driving the pain management therapeutics market as aged people are more prone to suffer from joint pain and other chronic conditions. The increasing incidences of chronic diseases such as cancer, diabetic neuropathy and osteoarthritis and rise in number of surgical procedures also further accelerate the pain management therapeutics market growth. The growth in awareness about availability of medications for pain management increasing the consumption and acceptance of pain management drugs over other treatment options and consumer inclination towards pain management therapeutics owning to its high availability, easy access, high awareness, cost effectiveness and quick relief also influence the pain management therapeutics market. Additionally, rise in healthcare expenditure, growth in awareness regarding diseases, enhancing healthcare infrastructure, research and development activities and surge in healthcare expenditure positively affect the pain management therapeutics market. Furthermore, research and development activities and innovations in products extend profitable opportunities to the pain management therapeutics market players in the forecast period of 2021 to 2028.
On the other hand, the rise in concerns regarding drug exploitation and patent expiration of prescription pain medication drugs are the factors expected to obstruct the pain management therapeutics market growth. The availability of substitutes such as pain relief devices is projected to challenge the pain management therapeutics market in the forecast period of 2021 to 2028.
This pain management therapeutics market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on pain management therapeutics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Pain Management Therapeutics Market Scope and Market Size
The pain management therapeutics market is segmented on the basis of pain type, drug class and indication. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of pain type, the pain management therapeutics market is segmented into chronic and acute.
- On the basis of drug class, the pain management therapeutics market is segmented into NSAIDS, anesthetics, anticonvulsant, anti-migraine drugs, antidepressant drugs, opioids, non-narcotics and analgesics.
- On the basis of indication, the pain management therapeutics market is segmented into arthritic pain, neuropathic pain, cancer pain, chronic pain, post-operative pain, migraine, fibromyalgia, bone fracture, muscle sprain/strain, acute appendicitis and other indications.
Global Pain Management Therapeutics Market Country Level Analysis
The pain management therapeutics market is analyzed and market size insights and trends are provided by country, pain type, drug class and indication as referenced above.
The countries covered in the pain management therapeutics market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the pain management therapeutics market due to the large number of aging population and favorable regulatory conditions. Asia-Pacific is expected to witness the highest growth rate during the forecast period of 2021 to 2028 because of the presence of larger patient pool and increase in healthcare expenditure in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The pain management therapeutics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for pain management therapeutics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the pain management therapeutics market. The data is available for historic period 2011 to 2019.
Competitive Landscape and Pain Management Therapeutics Market Share Analysis
The pain management therapeutics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to pain management therapeutics market.
The major players covered in the pain management therapeutics market report are Pfizer Inc., Assertio Holdings, Inc., Endo International plc, Purdue Pharma L.P., Mallinckrodt, Teva Pharmaceutical Industries Ltd, Novartis AG, AstraZeneca, Johnson & Johnson Services, Inc., Merck & Co., Inc., Abbott, GlaxoSmithKline plc, Eli Lilly and Company, Viatris Inc., Hisamitsu Pharmaceutical Co.,Inc., CALMAR PAIN RELIEF, LLC, Calmare Therapeutics Incorporated, Allergan, F. Hoffmann-La Roche Ltd among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-